Tvardi Therapeutics is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases. Founded in 2017 and based in Houston, Texas, the company is led by experienced entrepreneurs, innovative scientists and dedicated physicians.

Biotechnology

Tvardi Therapeutics

Tvardi Therapeutics' headquarters in Houston, TX, United States

Imran Alibhai

Susan Shiff

Kari Anne Rowland

Jeffrey Larson, PhD, DABT

Riley Gaddy, MBA

Dan Conn

Yixin Chen

Sofia de Achaval

Jeff Larson

Wallace Hall

Michael Wyzga

Sujal Shah

David Tweardy

Ravi I. Thadhani

Michael T. Lewis

Ron DePinho

Keith T. Flaherty

James P. Allison

Jamie McNab

Description

People (7)

Imran Alibhai

Jeff Larson

Michael T. Lewis

Jeffrey Larson, PhD, DABT

Sara Manning

Nicole Goodwin

John Kauh

Jobs